financetom
Market
financetom
/
Market
/
Hindustan Unilever says overall commodity inflation still significantly elevated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hindustan Unilever says overall commodity inflation still significantly elevated
Oct 21, 2022 8:36 AM

Share Market Live

NSE

Hindustan Unilever said that it managed to maintain its operating margin despite "unprecedented inflation" in input costs. The management said that overall commodity inflation is significantly elevated as prices of sugar and cereals remain on the higher side.

The FMCG major reported volume growth of 4 percent during the September quarter, in-line with a CNBC-TV18 poll that had pegged the volume growth to be between 4-5 percent.

While the management said that volume growth for the company was positive, the industry is still going through a period of negative volume growth.

However, the management is "cautiously optimistic" as September turned out to be a very good month for the company.

The company's revenue of Rs 14,751 crore was marginally below the poll estimate of Rs 14,805 crore. On a year-on-year basis, revenue increased 15.9 percent.

Net profit for the period increased nearly 20 percent to Rs 2,616 crore, which turned out to be higher than the CNBC-TV18 poll of Rs 2,425 crore.

Operational performance also was largely in-line with expectations. EBITDA at Rs 3,377 crore increased 7.8 percent from last year, but was lower than the expectation of Rs 3,415 crore. Margin contracted 170 basis points from last year to 22.9 percent, but was only 20 basis points lower than the poll of 23.1 percent.

Gross margin for the HUL stood at 45.8 percent, which is a multi-quarter low.

The company's margin missed expectations despite a cut back in advertising and promotional expenses during the quarter. Overall A&P expense stood at Rs 1,041 crore compared to Rs 1,215 crore in September last year and Rs 1,328 crore during the June quarter. The management expects advertising expenses to ramp up amidst the festive season.

Among various business segments, the homecare business managed to outperform expectations while growth in Beauty & Personal care and Food & Refreshments turned out to be below what the street anticipated.

First Published:Oct 21, 2022 5:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Health Care
Sector Update: Health Care
Aug 26, 2024
08:55 AM EDT, 08/26/2024 (MT Newswires) -- Health care stocks were steady pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. BeiGene ( BGNE ) shares were up more than 2% after saying BGB-16673 received fast track designation from the US Food and Drug Administration for potentially treating relapsed or...
Sector Update: Financial
Sector Update: Financial
Aug 26, 2024
08:57 AM EDT, 08/26/2024 (MT Newswires) -- Financial stocks were advancing premarket Monday, with The Financial Select Sector SPDR Fund (XLF) 0.3% higher. The Direxion Daily Financial Bull 3X Shares (FAS) was 1% higher and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was down 1.2%. Prestige Wealth ( PWM ) shares were up past 118% after the...
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Aug 26, 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for...
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
Aug 26, 2024
Aurora Cannabis Inc. ( ACB ) has partnered with Vectura Fertin Pharma, Inc. to launch a CBD lozenge in the form of a dissolvable tablet that delivers the precise dose of cannabidiol (CBD). The new product is expected to enhance patient care by providing an alternative consumption method without psychoactive effects. The partnership leverages Aurora’s extensive medical cannabis patient platform,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved